Understanding CKD among patients with T2DM: prevalence, temporal trends, and treatment patterns-NHANES 2007-2012.

Wu, Bingcao; Bell, Kelly; Stanford, Amy; Kern, David M; Tunceli, Ozgur; Vupputuri, Suma; Kalsekar, Iftekhar; Willey, Vincent

Wu, Bingcao; Bell, Kelly; Stanford, Amy; Kern, David M; Tunceli, Ozgur; Vupputuri, Suma; Kalsekar, Iftekhar; Willey, Vincent.

Afiliación

Wu B; HealthCore Inc. , Wilmington, Delaware , USA.
Bell K; AstraZeneca R&D , Fort Washington, Pennsylvania , USA.
Stanford A; Bristol-Myers Squibb Company , Plainsboro, New Jersey , USA.
Kern DM; HealthCore Inc. , Wilmington, Delaware , USA.
Tunceli O; HealthCore Inc. , Wilmington, Delaware , USA.
Vupputuri S; HealthCore Inc. , Wilmington, Delaware , USA.
Kalsekar I; AstraZeneca R&D , Fort Washington, Pennsylvania , USA.
Willey V; HealthCore Inc. , Wilmington, Delaware , USA.

BMJ Open Diabetes Res Care ; 4(1): e000154, 2016.

Article en En | MEDLINE | ID: mdl-27110365

Palabras clave

Health Care Management; Kidney Disorder; Kidney Failure; Kidney Function Test

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Guideline / Prevalence_studies / Qualitative_research / Risk_factors_studies Idioma: En Revista: BMJ Open Diabetes Res Care Año: 2016 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google